中国病理生理杂志
中國病理生理雜誌
중국병리생리잡지
CHINESE JOURNAL OF PATHOPHYSIOLOGY
2015年
5期
808-811
,共4页
刘少军%李沅美%刘慰华%熊龙根%刘世明
劉少軍%李沅美%劉慰華%熊龍根%劉世明
류소군%리원미%류위화%웅룡근%류세명
p38 MAPK/ATF-2通路%C反应蛋白%内皮细胞活化%动脉粥样硬化
p38 MAPK/ATF-2通路%C反應蛋白%內皮細胞活化%動脈粥樣硬化
p38 MAPK/ATF-2통로%C반응단백%내피세포활화%동맥죽양경화
p38 MAPK/ATF-2 pathway%C-relative protein%Endothelial activation%Atherosclerosis
目的:考察p38 MAPK/ATF-2通路在C反应蛋白( CRP)诱导的内皮细胞活化中的作用。方法:采用培养的人冠状动脉内皮细胞( HCAEC)第3~7代用于实验。 CRP刺激诱导内皮细胞活化,给予p38抑制剂SB203580和SB202190干预。免疫印迹法检测p-eNOS、p-p38和p-ATF2的水平;ELISA法测定HCAEC分泌的黏附分子ICAM-1、VCAM-1和MCP-1的变化。结果: CRP呈浓度依赖性地抑制p-eNOS水平, CRP诱导HCAEC分泌ICAM-1、VCAM-1和MCP-1;CRP激活p38/ATF-2通路;SB203580和SB202190部分恢复p-eNOS水平和抑制CRP诱导的ICAM-1、VCAM-1和MCP-1分泌。结论:p38 MAPK/ATF-2通路参与CRP诱导的HCAEC活化。
目的:攷察p38 MAPK/ATF-2通路在C反應蛋白( CRP)誘導的內皮細胞活化中的作用。方法:採用培養的人冠狀動脈內皮細胞( HCAEC)第3~7代用于實驗。 CRP刺激誘導內皮細胞活化,給予p38抑製劑SB203580和SB202190榦預。免疫印跡法檢測p-eNOS、p-p38和p-ATF2的水平;ELISA法測定HCAEC分泌的黏附分子ICAM-1、VCAM-1和MCP-1的變化。結果: CRP呈濃度依賴性地抑製p-eNOS水平, CRP誘導HCAEC分泌ICAM-1、VCAM-1和MCP-1;CRP激活p38/ATF-2通路;SB203580和SB202190部分恢複p-eNOS水平和抑製CRP誘導的ICAM-1、VCAM-1和MCP-1分泌。結論:p38 MAPK/ATF-2通路參與CRP誘導的HCAEC活化。
목적:고찰p38 MAPK/ATF-2통로재C반응단백( CRP)유도적내피세포활화중적작용。방법:채용배양적인관상동맥내피세포( HCAEC)제3~7대용우실험。 CRP자격유도내피세포활화,급여p38억제제SB203580화SB202190간예。면역인적법검측p-eNOS、p-p38화p-ATF2적수평;ELISA법측정HCAEC분비적점부분자ICAM-1、VCAM-1화MCP-1적변화。결과: CRP정농도의뢰성지억제p-eNOS수평, CRP유도HCAEC분비ICAM-1、VCAM-1화MCP-1;CRP격활p38/ATF-2통로;SB203580화SB202190부분회복p-eNOS수평화억제CRP유도적ICAM-1、VCAM-1화MCP-1분비。결론:p38 MAPK/ATF-2통로삼여CRP유도적HCAEC활화。
AIM:To investigate the role of p38 MAPK/ATF-2 pathway in C-relative protein ( CRP)-induced endothelial cell activation.METHODS:Human coronary artery endothelial cells ( HCAEC) were cultured and were used between passages 3 and 7.CRP served as a stimulus for endothelial cell activation.Western blotting was performed to de-termine the expression and phosphorylation of eNOS, p38 and ATF2.ELISA was carried out to detect the levels of ICAM-1, VCAM-1 and MCP-1 released from HCAEC.Pharmacological p38 inhibitors SB203580 and SB202190 were used to de-termine the effect of p38/ATF-2 pathway.RESULTS:CRP reduced the p-eNOS level in a concentration-dependent man-ner and induced the release of ICAM-1, VCAM-1 and MCP-1.The p38/ATF-2 pathway was activated by CRP treatment. SB203580 and SB202190 partially rescued p-eNOS level and suppressed the secretion of ICAM-1, VCAM-1 and MCP-1. CONCLUSION:p38MAPK/ATF-2 pathway participates in CRP-induced endothelial activation.